Bill > H1142

This bill requires various health insurance plans in Massachusetts, including those offered through the Group Insurance Commission, Medicaid, private insurers, and health maintenance organizations, to provide coverage for opioid antagonists like naloxone with no patient cost-sharing. The bill defines "opioid antagonists" as drugs approved by the FDA to reverse opioid overdoses. It also specifies that a prescription is not required for coverage of these drugs under the statewide standing order. The goal of the bill is to improve access to opioid reversal medications and reduce barriers to their use in addressing the opioid crisis.

Business and Industry, Health and Social Services

https://malegislature.gov/Bills/193/H1142